HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CHPA President

This article was originally published in The Rose Sheet

Executive Summary

FDA Senior Associate Commissioner for Communications and Constituent Relations Linda Suydam to head CHPA as president after leaving her post June 1. Suydam, who has worked for FDA for 21 years, has managed agency activities including orphan products, special health and women's health, FDA says. CHPA board member Robert Donovan has served as interim president since Jan. 15 following the departure of President Michael Maves, MD (1"The Rose Sheet" Dec. 24, 2001, In Brief)...

You may also be interested in...



CHPA interim prez

Consultant and longtime board member Robert Donovan will assume leadership post Jan. 15 upon departure of President Michael Maves, MD. Donovan and his wife will take up residence in D.C. area while maintaining their Connecticut home. An OTC industry veteran with ties to supplement industry, Donovan accepted CHPA Chairman Michael Valentino's job offer Dec. 16, is slated to visit association's offices the week of Dec. 24 and begin work Jan 2. Currently president of the Council on Family Health, Donovan said he will remain involved with the nonprofit educational organization through his leadership role at CHPA but would turn over decision-making duties to CFH Chairman Arthur Hayes, MD. Search for Maves' permanent replacement expected to take about six months...

Impella Safety Update: Data Supports Pump For Qualified Patients

Updated data from a postmarket study of Abiomed’s Impella RP right-heart pump further supports the device’s safety for a specific patient population.

Quality, Safety, MDSAP A Focus For Medtech In New USMCA Trade Agreement

The new US-Mexico-Canada (USMCA) trade agreement includes language on enhancing regulatory compatibility between the three countries by recognizing quality systems audits performed under the Medical Device Single Audit Program (MDSAP). It also stipulates that each trading partner “consider its resources and technical capacity” in ensuring the safety, effectiveness and quality of devices – and more. Medtech industry advocacy group AdvaMed is praising the deal, reached by the three countries on 10 December.

UsernamePublicRestriction

Register

RS010272

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel